Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Current Deferred Revenue (2017 - 2025)

cbdMD's Current Deferred Revenue history spans 8 years, with the latest figure at $488626.0 for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 7.36% to $488626.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $488626.0, a 7.36% decrease, with the full-year FY2025 number at $506289.0, up 0.6% from a year prior.
  • Current Deferred Revenue hit $488626.0 in Q4 2025 for cbdMD, down from $506289.0 in the prior quarter.
  • Over the last five years, Current Deferred Revenue for YCBD hit a ceiling of $557353.0 in Q1 2025 and a floor of $755.0 in Q2 2021.
  • Historically, Current Deferred Revenue has averaged $429667.4 across 4 years, with a median of $504771.5 in 2024.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 171.67% in 2024 and later fell 7.43% in 2025.
  • Tracing YCBD's Current Deferred Revenue over 4 years: stood at $755.0 in 2021, then soared by 24435.89% to $185246.0 in 2023, then soared by 184.72% to $527438.0 in 2024, then fell by 7.36% to $488626.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for YCBD at $488626.0 in Q4 2025, $506289.0 in Q3 2025, and $509198.0 in Q2 2025.